SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haulica, I.
Right arrow Articles by Neagu, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haulica, I.
Right arrow Articles by Neagu, B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
Hazardous Substances DB
*LOSARTAN POTASSIUM
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta

Ion Haulica

Laboratory of Experimental and Applied Physiology of the Romanian Academy Iasi, Romania, ihaulica{at}yahoo.com

Walther Bild

Department of Physiology, University of Medicine and Pharmacy Iasi, Romania

Christian N Mihaila

Department of Physiology, University of Medicine and Pharmacy Iasi, Romania

Teodor Ionita

Laboratory of Experimental and Applied Physiology of the Romanian Academy Iasi, Romania

Corneliu P Boisteanu

Laboratory of Experimental and Applied Physiology of the Romanian Academy Iasi, Romania

Bogdan Neagu

Laboratory of Experimental and Applied Physiology of the Romanian Academy Iasi, Romania

Using isolated rat aortic rings perfused with Krebs-Henseleit saline, the vascular effects of angiotensin (1-7) (Ang [1-7]) and its interactions with angiotensin II (Ang II) were investigated.

Ang (1-7) induced endothelium-dependent relaxation and vasodilating effects in preparations precontracted with phenylephrine. Without preconstriction, Ang (1-7) at high doses (10 -6—10-5 M) produced either a significant inhibition of Ang IIinduced vasoconstriction or a non-tachyphylactic vasopressor response. While losartan inhibited the vasoconstriction induced by Ang (1-7), A779 blocked only its relaxation. Unlike losartan, blockade of AT2-receptors with PD 123319 had no effect.

Taking into account the biphasic effects of angiotensin (1-7), we propose that it is one of the active components of the renin-angiotensin system, which is involved as a modulator both in the counter-regulatory actions of Ang II and in the self-regulation of its own vasodilating effects.

Key Words: vascular smooth muscle • angiotensin II • angiotensin (1-7)

References

  • Goodfriend TL Angiotensins - a family that grows from within. Hypertension 1991;17:139-40.[Free Full Text]
  • Bottari SP, De Gasparo M., Steckelings UM, Levens NR Angiotensin II receptor subtypes: characterization, signaling, mechanisms and possible physiological implications. Front Neuroendocrinol 1993;14:123-71.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Timmermans PBM, Smith RD Angiotensin II Rezeptoren: Physiologische und pharmakologische Bedeutung in Angiotensin II-Antagonismus. Th. Phillip and R.F. Schäfers (editors) Springer-Verlag Berlin, Heidelberg 1996, p 1-29.
  • Dina R., Jafari M. Angiotensin II-receptor antagonists: an overview. Am J Health-Syst Pharm 2000;57:1231-41.[Abstract/Free Full Text]
  • Changaris DG, Porter JL, Miller J., Levy RS Des-leu angiotensin I: biosynthesis and drinking response. Regul Pept 1988;20:273-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Benter IF, Diz DI, Ferrario CM Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin (1-7). Hypertension 1995;26:1138-44.[Abstract/Free Full Text]
  • Ferrario CM, Chappel MC, Tallant EA, Brosnihan KB, Diz DI Counter-regulatory actions of angiotensin (1-7). Hypertension 1997;30:535-41.[Abstract/Free Full Text]
  • Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM Release of vasopressin from the rat hypothalamoneurohypophysical system by angiotensin (1-7) heptapeptide. Proc Natl Acad Sci USA 1988;85:4095-8.[Abstract/Free Full Text]
  • Donoghue M., Hsieh F.,Baronas E. et al. A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circul Res 2000;87:c1-c9.
  • Santos RAS, Campagnole-Santos MI, Andrade SP Angiotensin (1-7) an update. Regul Pept 2000;91:45-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Santos RAS, Campagnole-Santos MI, Baracho NCV, Fontes MAP et al. Characterization of a new angiotensin antagonist selective for angiotensin (1-7); evidence that the actions of angiotensin (1-7) are mediated by specific angiotensin receptors. Brain Res Bull 1994;35:2938.
  • Tallant EA, Lu X., Weiss RB, Chappell MC, Ferrario CM Bovine aortic endothelial cells contain an angiotensin (1-7) receptor. Hypertension 1997;29:388-93.[Abstract/Free Full Text]
  • Hilchey SD, Bell-Quilley CP Association between the natriuretic action of angiotensin (1-7) and selective stimulation of renal prostaglandin release. Hypertension 1995;25:1238-44.[Abstract/Free Full Text]
  • Iyer SN, Yamada K., Diz DI, Ferrario CM, Chappell MC Evidence that prostaglandins mediates the antihypertensive actions of angiotensin (1-7). J Cardiovasc Pharmacol 2000; 36:109-17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Paula RD, Linea CV, Khosla MC, Santos RAS. Angiotensin (1-7) potentiates the hypotensive effect of bradykinin in conscious rats.Hypertension 1995;26:1150-9.
  • Brosnihan KB, Li P., Ferrario CM Angiotensin (1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996;27:523-8.[Abstract/Free Full Text]
  • Heitsch H., Brovkowych S., Malinski T., Wiener G. Angiotensin (1-7) stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001;37:72-6.[Abstract/Free Full Text]
  • Almeida AP, Frabregas BC, Madureira MH, Santos RJS. Angiotensin (1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Brazil J Med Biol Res 2000;33:709-13.[Web of Science][Medline] [Order article via Infotrieve]
  • Li P., Chappell MC, Ferrario MC, Brosnihan KB Angiotensin (1-7) augments bradykinin-induced vasodilatation by competing with ACE and releasing nitric oxide. Hypertension 1997; 29:394-400.[Abstract/Free Full Text]
  • Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA Angiotensin (1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996;28:104-08.[Abstract/Free Full Text]
  • Luque M., Martin P., Martell N., Fernandez P., Brosnihan KB, Ferrario CM Effects of captopril related to increased levels of prostacyclin and angiotensin (1-7) in essential hypertension. J Hypertens 1996;14:799-805.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yen le Tran A., Forster Chr. Angiotensin (1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol 1997;30:676-81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lemos VS, Cortes SF, Silva DM, Campagnole-Santos MJ, Santos RA Angiotensin (1-7) is involved in the endotheliumdependent modulation of phenylephrine-induced contraction in the rat aorta. Brit J Pharmacol 2002;135:143-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ferrario CM, Iyer SN Angiotensin (1-7): a bioactive fragment of the renin-angiotensin system.Regul Pept 1998;78:13-18.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Roks A., van Geel P., Pinto YM, Buikema H., Henning RH Angiotensin (1-7) is a modulator of the human reninangiotensin system. Hypertension 1999;34:296-301.[Abstract/Free Full Text]
  • Rowe BP, Saylor DL, Speth RC,Absher DR Angiotensin (17) binding at angiotensin II receptors in the rat brain. Regul Pept 1995;56:139-46.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ueda S., Masumori-Maemoto S.,Ashino K. et al. Angiotensin (1-7) attenuates vasoconstriction evoked by angiotensin II in man.Hypertension 2000;35:998-1001.[Abstract/Free Full Text]
  • Mahon JM, Carr RD, Nicol AK, Henderson TV Angiotensin (1-7) is an antagonist at the type I angiotensin II receptor. J Hypertens 1994;12:1377-81.[Web of Science][Medline] [Order article via Infotrieve]
  • van Rodijnen WF, van Lambalgen TA, van Wijhe MH, Tangelder GJ, Ter Wee PM Renal microvascular actions of angiotensin II fragments. Am J Physiol Renal Physiol 2002; 283:F86-F92.[Abstract/Free Full Text]
  • Moncada S., Palmer RMJ, Higgs EA Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-42.[Web of Science][Medline] [Order article via Infotrieve]
  • Pörsti I., BaraAT, Busse B., Hecker M. Release of nitric oxide by angiotensin (1-7) from porcine coronary endothelium. Brit J Pharmacol 1994;111:652-4.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 4, No. 2, 124-128 (2003)
DOI: 10.3317/jraas.2003.013


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. C. Q. Velez, A. M. Bland, J. M. Arthur, J. R. Raymond, and M. G. Janech
Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F398 - F407.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haulica, I.
Right arrow Articles by Neagu, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haulica, I.
Right arrow Articles by Neagu, B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
Hazardous Substances DB
*LOSARTAN POTASSIUM
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement